Skip to contentC
CareDx, Inc.
C
CDNACareDx, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$108.39M$108.39Mderived+25.2% vs Q4 2024 Net Income-$4.11M-$4.11MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$6,040,000N/M Operating Cash Flowderived$21,363,000−2.4% Margins · derivedOperating margin-5.6%−103.0 pt vs Q4 2024
Net margin-3.8%−105.1 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 25, 2026 · 56 d after period end